Pesquisa
Educação
Soluções
Entrar
PT
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Medical Oncology
Susan Fotheringham has not added Biography.
If you are Susan Fotheringham and would like to personalize this page please email our Author Liaison for assistance.
Genome-wide loss-of-function screen reveals an important role for the proteasome in HDAC inhibitor-induced apoptosis.
Cancer cell Jan, 2009 | Pubmed ID: 19111881
HR23B is a biomarker for tumor sensitivity to HDAC inhibitor-based therapy.
Proceedings of the National Academy of Sciences of the United States of America Apr, 2010 | Pubmed ID: 20308564
Dana-Farber Cancer Institute
Boston, MA
Susan Fotheringham1,2,
Keren Levanon1,2,3,
Ronny Drapkin1,2,4
1Department of Medical Oncology, Dana-Farber Cancer Institute,
2Harvard Medical School, Boston, MA,
3Sheba Cancer Research Center, Chaim Sheba Medical Center,
4Department of Pathology, Brigham and Women's Hospital
Privacidade
Termos de uso
Políticas
Entre em contato
recomende à biblioteca
Newsletter
JoVE Journal
Coleções de métodos
JoVE Encyclopedia of Experiments
Arquivo
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centro de Recursos para Docentes
Autores
Bibliotecários
Acesso
SOBRE A JoVE
Copyright © 2024 MyJoVE Corporation. Todos os direitos reservados